Cozad Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,589
Closed -$197K 355
2021
Q2
$197K Sell
1,589
-516
-25% -$64.8K 0.03% 331
2021
Q1
$249K Buy
2,105
+216
+11% +$25.3K 0.04% 309
2020
Q4
$221K Sell
1,889
-1,108
-37% -$122K 0.04% 299
2020
Q3
$311K Sell
2,997
-72
-2% -$7.23K 0.06% 244
2020
Q2
$281K Buy
3,069
+59
+2% +$5.66K 0.06% 257
2020
Q1
$271K Sell
3,010
-50
-2% -$5.32K 0.09% 177
2019
Q4
$347K Buy
3,060
+330
+12% +$36.2K 0.09% 181
2019
Q3
$297K Buy
2,730
+6
+0.2% +$626 0.09% 197
2019
Q2
$265K Sell
2,724
-395
-13% -$36.1K 0.08% 205
2019
Q1
$284K Buy
3,119
+137
+5% +$12.3K 0.09% 198
2018
Q4
$271K Buy
2,982
+320
+12% +$29.9K 0.09% 193
2018
Q3
$262K Buy
2,662
+101
+4% +$9.34K 0.08% 200
2018
Q2
$219K Buy
+2,561
New +$214K 0.07% 218

Other funds holding MDT

Cozad Asset Management's MDT Position: Q3 2021 in Review

Cozad Asset Management sold out of Medtronic (MDT) in Q3 2021, closing a stake of 1,589 shares — an estimated $197K sold.

Cozad Asset Management first reported a position in MDT in Q2 2018 and held it in 13 quarters. The position peaked at $347K in Q4 2019. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • Cozad Asset Management reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
  • Cozad Asset Management sold 1,589 Medtronic shares in Q3 2021, an estimated $197K.
  • Cozad Asset Management first reported a position in Medtronic in Q2 2018 and held it in 13 quarters.
  • Cozad Asset Management's Medtronic position peaked at $347K in Q4 2019.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Cozad Asset Management's 13F filing for Q3 2021, filed 5 Nov 2021.